ACO Name and Location
- Privia Quality Network Gulf Coast II, LLC
- 950 N Glebe Rd Suite 700
- Arlington, VA 22203
ACO Primary Contact
Lynne Vaassen
Phone: 713-512-7001
Email: lvaassen@priviahealth.com
Organizational Information
ACO Participants:
ACO Participants | ACO Participant in Joint Venture |
---|---|
Benjamin Adam Stahl M.D., P.A. | N |
Camille Goff | N |
Cheryl Clark-Brown | N |
Complete Care Obgyn And Family Medicine PLLC | N |
Doctors Clinic Of Spokane P S | N |
Edward Kuo, M.D., P.A. | N |
Family Medicine Associates Of Conroe PLLC | N |
Family Practice Associates, P.A. | N |
Gary L. Gilcrease M.D., P.A. | N |
Hospital Internists Of Texas Clinic PLLC | N |
Jennifer Gwozdz | N |
Lewis Family Medicine | N |
Lori Naglieri, M.D., P.A. | N |
Medina Lake Clinic P.A. | N |
Narendra Punjabi M.D., P.A. | N |
Privia Medical Group Gulf Coast PLLC | N |
Privia Medical Group West Texas PLLC | N |
San Antonio Family Physicians | N |
Spangler Medical Enterprises, P.A. | N |
St. Elizabeth Family Care, LLC | N |
Waco Primary Care, P.A. | N |
Walla Walla Clinic, Inc. | N |
ACO Governing Body:
Member First Name | Member Last Name | Member Title/Position | * Member’s Voting Power – Expressed as a percentage | Membership Type | ACO Participant TIN Legal Business Name/DBA, if Applicable |
---|---|---|---|---|---|
Keith | Fernandez, MD | Director | 6.250% | ACO Executive | N/A |
Mark | Cone | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Mark | Florian | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Thimos | Paschalis | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Christopher | Prihoda | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Susan | Vogel | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Daniel | Dawson | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Allen | Lee | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast II, PLLC |
Lynne | Vaassen | Director | 6.250% | VP Population Health, Privia Health | N/A |
David | Dunwoody | Director | 6.250% | Medicare Beneficiary Representative | N/A |
Evan | Varadi | Director | 6.250% | RVP Practice Operations, Privia Health | N/A |
* –Due to rounding, ‘Member’s Voting Power’ may not equal 100 percent.
Key ACO Clinical and Administrative Leadership:
- ACO Executive: Keith Fernandez, MD
- Medical Director: Keith Fernandez, MD
- Compliance Officer: Stephanie Clark
- Quality Assurance/Improvement Officer: Tiffany Johnson
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name & Position |
---|---|
Finance Committee | David Mountcastle |
Quality Assurance Committee | Christopher Prihoda, M.D. – Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Second Agreement Period
- Performance Year 2023: $9,610,568.36
- Performance Year 2022: $7,631,504.64
- First Agreement Period
- Performance Year 2021: $5,344,749.41
- Performance Year 2020: $5,091,075.46
- Performance Year 2019: $2,470,186.33
- Performance Year 2018: $4,203,425
Shared Savings Distribution
-
- Second Agreement Period
- Performance Year 2023
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2022
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2023
- First Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2019
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2021
- Second Agreement Period
Quality Performance Results
2023 Quality Performance Results:
Quality Performance Results are based on CMS Web Interface Measure Set
Measure # | Measure Name | Collection Type | Reported Performance Rate | Current Year Mean Performance Rate (SSP ACOs) |
---|---|---|---|---|
Measure # 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | CMS Web Interface | 6.04 | 9.84 |
Measure # 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 86.90 | 80.97 |
Measure # 236 | Controlling High Blood Pressure | CMS Web Interface | 85.52 | 77.80 |
Measure # 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 92.71 | 89.42 |
Measure # 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 80.18 | 70.76 |
Measure # 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 100.00 | 79.29 |
Measure # 113 | Colorectal Cancer Screening | CMS Web Interface | 84.26 | 77.14 |
Measure # 112 | Breast Cancer Screening | CMS Web Interface | 80.88 | 80.36 |
Measure # 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 90.25 | 87.05 |
Measure # 370 | Depression Remission at Twelve Months | CMS Web Interface | 25.00 | 16.58 |
Measure # 321 | CAHPS for MIPS | CMS Web Interface | 7.84 | 6.25 |
Measure # 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | CMS Web Interface | 0.1554 | 0.1553 |
Measure # 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | CMS Web Interface | — | 35.39 |
CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 82.98 | 83.68 |
CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 93.71 | 93.69 |
CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 93.29 | 92.14 |
CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 81.25 | 75.97 |
CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 65.15 | 63.93 |
CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 62.61 | 61.60 |
CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 76.68 | 74.12 |
CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 88.36 | 85.77 |
CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 92.40 | 92.31 |
CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 32.80 | 26.69 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov